Recon: FDA denies Lykos MDMA drug; Pfizer reports positive late-stage results for RSV vaccine in immunocompromised adults
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)